WASHINGTON — The Supreme Court ensured Thursday that the abortion pill mifepristone can continue to be available by mail without an in-person appointment with a clinician.

A ruling by the New Orleans-based 5th U.S. Circuit Court of Appeals on May 1 had imperiled widespread access to the pill. Now, the Supreme Court has granted emergency requests brought by drugmakers Danco Laboratories and GenBioPro seeking to block that ruling.

The decision , a loss for the state of Louisiana, ensures there will not be any disruption to the availability of the drug as litigation continues.…